Interim Report 2015-01-01 – 2015-09-30
The board and CEO of Oncology Venture Sweden AB hereby announces its report for the third quarter of 2015. Summary of Interim Report Operations of the group’s controlling company, Oncology Venture Sweden AB, started on June 4:th 2015. Hence, the group relationship was established on this date, and comparable periods are not yet available. Approximately four months (2015-06-04 – 2015-09-30) • Net sales: 446.000 SEK. • Profit after financial items: -4.521.000 SEK. • Cash and Bank 23.692.000 SEK. • Earnings per share: -0,63 SEK. • Solidity: